AU2002239405A1 - Tetrapartate prodrugs - Google Patents

Tetrapartate prodrugs

Info

Publication number
AU2002239405A1
AU2002239405A1 AU2002239405A AU3940502A AU2002239405A1 AU 2002239405 A1 AU2002239405 A1 AU 2002239405A1 AU 2002239405 A AU2002239405 A AU 2002239405A AU 3940502 A AU3940502 A AU 3940502A AU 2002239405 A1 AU2002239405 A1 AU 2002239405A1
Authority
AU
Australia
Prior art keywords
tetrapartate
prodrugs
tetrapartate prodrugs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002239405A
Inventor
Richard B Greenwald
Hong Zhao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Enzon Pharmaceuticals Inc
Original Assignee
Enzon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/758,993 external-priority patent/US6720306B2/en
Application filed by Enzon Inc filed Critical Enzon Inc
Publication of AU2002239405A1 publication Critical patent/AU2002239405A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyethers (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU2002239405A 2000-12-01 2001-11-30 Tetrapartate prodrugs Abandoned AU2002239405A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US72851200A 2000-12-01 2000-12-01
US09/728,512 2000-12-01
US09/758,993 2001-01-12
US09/758,993 US6720306B2 (en) 1997-12-17 2001-01-12 Tetrapartate prodrugs
PCT/US2001/045127 WO2002043663A2 (en) 2000-12-01 2001-11-30 Tetrapartate prodrugs

Publications (1)

Publication Number Publication Date
AU2002239405A1 true AU2002239405A1 (en) 2002-06-11

Family

ID=27111706

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002239405A Abandoned AU2002239405A1 (en) 2000-12-01 2001-11-30 Tetrapartate prodrugs

Country Status (5)

Country Link
EP (1) EP1343494A4 (en)
JP (1) JP2004518776A (en)
AU (1) AU2002239405A1 (en)
CA (1) CA2428018A1 (en)
WO (1) WO2002043663A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6624142B2 (en) * 1997-12-30 2003-09-23 Enzon, Inc. Trimethyl lock based tetrapartate prodrugs
ATE385239T1 (en) * 2002-05-08 2008-02-15 Medical Enzymes Ag PROTECTIVE REAGENTS CONTAINING ACTIVE CARBOHYDRATES FOR CHEMICAL MODIFICATIONS, THEIR PRODUCTION AND USE
WO2005030835A1 (en) * 2003-09-25 2005-04-07 Terumo Kabushiki Kaisha Polyethylene glycol derivatives and drug carriers containing the same as the membrane constituent
CN100415801C (en) * 2003-10-28 2008-09-03 北京键凯科技有限公司 Polyethylene glycol amino acid N-internal ring carbonyl anhydride active derivatives, and medicinal bonding compound and gel thereof
CN100543063C (en) * 2006-04-03 2009-09-23 中国科学院过程工程研究所 Polyethyleneglycol of end group of amino acid and preparation method thereof
WO2008034122A2 (en) * 2006-09-15 2008-03-20 Enzon Pharmaceuticals, Inc. Hindered ester-based biodegradable linkers for oligonucleotide delivery
MX2009002854A (en) * 2006-09-15 2009-03-27 Enzon Pharmaceuticals Inc Polyalkylene oxides having hindered ester-based biodegradable linkers.
DE102011118029A1 (en) 2011-06-20 2012-12-20 Universität Leipzig Modified antibiotic peptides with variable systemic release
WO2014075035A1 (en) 2012-11-12 2014-05-15 Cephalon, Inc. Bendamustine derivatives and methods of using same
US10040850B2 (en) 2013-10-08 2018-08-07 Ascendis Pharma A/S Protecting group comprising a purification tag

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9501052D0 (en) * 1995-01-19 1995-03-08 Cancer Res Campaign Tech Improvements relating to prodrugs
DK0751144T3 (en) * 1995-06-27 2004-12-27 Pharmachemie Bv New anthracycline pro-drugs, processes for their preparation, and anti-tumor compositions and a component kit containing these pro-drugs
CA2312975C (en) * 1997-12-17 2012-08-21 Enzon, Inc. Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents

Also Published As

Publication number Publication date
WO2002043663A2 (en) 2002-06-06
WO2002043663A3 (en) 2002-07-25
EP1343494A2 (en) 2003-09-17
CA2428018A1 (en) 2002-06-06
JP2004518776A (en) 2004-06-24
EP1343494A4 (en) 2005-08-03

Similar Documents

Publication Publication Date Title
AU6419701A (en) Electropancreatography
AU2001262847A1 (en) Language-understanding
AU2001228708A1 (en) Coin-validation arrangement
AU2001292739A1 (en) 1-oxorapamycins
AU2000267458A1 (en) Hypercomputer
AU2001254546A1 (en) Aminopiperidines
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001220246A1 (en) Neckphone
AU2002211620A1 (en) Autoanastomosis
AU2001258349A1 (en) Bisacylguanidine
AU2001296577A1 (en) Chlorophyllases
AU2001279754A1 (en) Indoloquinazolinones
AU2002239403A1 (en) Tissue specific prodrugs
AU2001285886A1 (en) 2-guanidino-4-aryl-quinazoline
AU2002211128A1 (en) Step-bike
AU2001290931A1 (en) Ski-snowboard
AUPR059400A0 (en) Formaldehyde-releasing prodrugs
AU2001293852A1 (en) Sulfonylguanidine
AU2001258924A1 (en) Microsatellite-aflp
AU2002226346A1 (en) 2-aryl-5-trifluoromethylpyridines
AU2002239405A1 (en) Tetrapartate prodrugs
AU5310500A (en) Pseudomycin prodrugs
AU2001281921A1 (en) Bdellosomes
AU2001246864A1 (en) Hypotensors
AU2001291876A1 (en) Triazolo-epothilones